Webinar banner
Q&A Conference Call with the CEO - InSitu Biologics
As a prospective investor we invite you to join InSitu Biologic's CEO Jim Segermark for a conference call to answer your questions.

Jim will be available to address your questions regarding our Matrix BioHydrogel, and our pre-clinical stage, long-lasting and long-acting non-opiate painkiller, AnestaGel™ & AniGel™ as well as the Regulation A+ offering and making your online investment.

This format allows for you to interact as much or as little as you’d like and you can even just simply listen in.
Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Jim Segermark.